FDA Blesses Heart Pump for Right Heart Failure

The FDA approved Abiomed’s PMA for its new Impella RP heart pump.

The device is designed to deliver flow and pressure without the need for surgical insertion. It stabilizes a patient’s hemodynamics by providing more than four liters of blood per minute.

It is the only percutaneous temporary ventricular support device for treating acute right heart failure that has received the agency’s approval, according to Abiomed.